Influence of Helicobacter pylori infection on the phenotype of Crohn's disease

American Journal of Gastroenterology

Volumn 94, Issue 11, 1999, Pages 3239-3244

  Püspök, Andreas ^a   Dejaco, Clemens ^a   Oberhuber, Georg ^b   Waldhör, Thomas ^c   Hirschl, Alexander M ^d   Vogelsang, Harald ^a   Gasche, Christoph ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Institute of Tumorbiology and Cancer Research   (Austria)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE DURATION; FEMALE; FOLLOW UP; GASTROSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE RESECTION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SMOKING HABIT; STOMACH BIOPSY;

ADULT; BIOPSY; COLONIC DISEASES; CONFIDENCE INTERVALS; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINE, SMALL; LOGISTIC MODELS; MALE; PHENOTYPE; POISSON DISTRIBUTION; SMOKING; STOMACH;

EID: 0344129028     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00587-0     Document Type: Article

References (26)

1. Koutroubakis I., Manousos O.N., Meuwissen S.G.M., et al. Environmental risk factors in inflammatory bowel disease. Hepato Gastroenterol. 43:1996;381-393.
2. Rutgeerts P., Goboes K., Peeters M., et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 338:1991;771-774.
3. Kühn R., Löhler J., Rennick D., et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274.
4. Sadlack B., Merz H., Schorle H., et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:1993;253-261.
5. 2 microglobulin transgenic rats. J Clin Invest. 98:1996;945-953.
6. Peppercorn M.A. Is there a role for antibiotics as primary therapy in Crohn's ileitis? J Clin Gastroenterol. 17:1993;235-237.
7. Gui G.P., Thomas P.R., Tizard M.L., et al. Two-year-outcomes analysis of Crohn's disease treated with rifabutin, and macrolide antibiotics. J Antimicrob Chemother. 39:1997;393-400.
8. Fox J.G., Dewhirst F.E., Tully J.G., et al. Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers, and intestinal mucosal scrapings from mice. J Clin Microbiol. 32:1994;1238-1245.
9. Cahill R.J., Foltz C.J., Fox J.G., et al. Inflammatory bowel disease An immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus . Infect Immun. 65:1997;3126-3131.
10. Epidemiology of and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut. 34:1993;1672-1676.
11. Webb P.M., Knight T., Greavers S., et al. Relation between infection with Helicobacter pylori and living conditions in childhood Evidence for person to person transmission in early life . Br Med J. 308:1994;750-753.
12. Kelly S.M., Pitcher M.C., Farmery S.M., et al. Isolation of Helicobacter pylori from faeces of patients with dyspepsia in the United Kingdom. Gastroenterology. 107:1994;1671-1674.
13. Ernst P.B., Crowe S.E., Reyes V.E. The immunopathogenesis of gastroduodenal disease associated with Helicobacter pylori infection. Curr Opin Gastroenterol. 11:1995;512-518.
14. Greenstein A.J., Lachman P., Sachar D.B., et al. Perforating and non-perforating indications for repeated operations in Crohn's disease Evidence for two clinical forms . Gut. 29:1988;588-592.
15. Lautenbach E., Berlin J.A., Lichtenstein G.R. Risk factors for early postoperative recurrence of Crohn's disease. Gastroenterology. 115:1998;259-267.
16. Hosmer D.W.I., Lemeshow S. Applied logistic regression. 1989;John Wiley & Sons, Inc, New York.
17. Smoot D.T., Mobley H.L., Chippendale G.R., et al. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun. 58:1990;1992-1994.
18. Duchmann R., Märker-Hermann E., Meyer zum Büschenfelde K.H. Bacteria-specific T-cell clones are selective in their reactivity towards different Enterobacteria or H. pylori and increased in inflammatory bowel disease. Scand J Immunol. 44:1996;71-79.
19. Negrini R., Lisato L., Zanella I., et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology. 101:1991;437-445.
20. Wakefield A.J., Sawyerr A.M., Dhillon A.P., et al. Pathogenesis of Crohn's disease Multifocal gastrointestinal infarction . Lancet. 2:1989;1057-1062.
21. Elizalde J.I., Gomez L., Panes J., et al. Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest. 100:1997;996-1005.
22. Farmer R.G., Whelan G., Fazio V.W. Long-term follow-up of patients with Crohn's disease. Relationship between clinical pattern and prognosis. Gastroenterology. 88:1985;1818-1825.
23. Thomas J.E., Whatmore A.M., Barer M.R., et al. Serodiagnosis of Helicobacter pylori infection in childhood. J Clin Microbiol. 28:1990;2641-2646.
24. Sutherland L.R., Ramcharan S., Bryant H., et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology. 98:1990;1123-1128.
25. Lindberg E., Järnerot G., Huitfeldt B. Smoking in Crohn's disease. Effect on localisation and clinical course. Gut. 33:1992;779-782.
26. Oberhuber G., Püspök A., Oesterreicher C., et al. Focally enhanced gastritis A frequent type of gastritis in patients with Crohn's disease . Gastroenterology. 112:1997;698-706.